Related Experiment Videos
Ischemic heart disease secondary to amyloidosis of intramyocardial arteries
Insights
Cardiac amyloidosis can cause severe heart problems by blocking small arteries within the heart muscle. This amyloidosis leads to ischemic injury and can result in heart failure.
Area of Science:
- Cardiovascular Pathology
- Amyloidosis Research
- Cardiac Medicine
Background:
- Cardiac amyloidosis is a condition where amyloid protein deposits in the heart.
- Amyloid infiltration can affect the heart's structure and function.
- Previous studies have focused on amyloid deposition in the heart muscle itself.
Purpose of the Study:
- To investigate the role of intramyocardial artery amyloidosis in cardiac pathology.
- To determine the clinical and pathological significance of amyloid deposits in small cardiac vessels.
- To understand the contribution of intramyocardial arterial amyloidosis to ischemic heart disease.
Main Methods:
- Autopsy study of 108 patients with cardiac amyloidosis.
- Histopathological examination of heart tissue, focusing on intramyocardial arteries.
- Correlation of pathological findings with clinical records, including heart failure, arrhythmias, and angina.
Main Results:
- Five patients (4.6%) exhibited severe, occlusive amyloid deposits in intramyocardial arteries.
- These affected vessels supplied areas of focal subendocardial ischemic injury.
- Clinical presentations included congestive heart failure, arrhythmias, and angina pectoris, unrelated to epicardial coronary artery disease.
Conclusions:
- Amyloidosis of intramyocardial arteries can cause localized ischemic necrosis in the heart.
- This vascular amyloidosis is a potential cause of intractable congestive heart failure due to widespread ischemic injury.
- Intramyocardial artery amyloidosis represents a distinct mechanism of cardiac dysfunction in amyloidosis.
Abstract:
Among 108 patients with cardiac amyloidosis studied at autopsy between 1889 and 1977 there were 5 (4.6 percent) with severe occlusive amyloid deposits in intramyocardial arteries. The hearts of all five patients showed focal subendocardial ischemic injury, and the vessels supplying these areas had either complete or near complete luminal obliteration by amyloid. Clinically, four patients had congestive heart failure; one of these patients also had arrhythmias and one had angina pectoris. Neither the clinical nor the pathologic features of ischemic heart diseases could be attributed to disease of the epicardial coronary arteries. Amyloidosis of the intramyocardial arteries appears to be capable of producing localized areas of ischemic necrosis and may produce intractable congestive heart failure due to multiple areas of ischemic injury.